# data[].attributes.body
With William Wart

# data[].attributes.body
With Dr Debbie Diddler

# data[].attributes.headline
Cost information for proposed new services

# data[].attributes.subject
Cost information for proposed new services

# data[].attributes.headline
                                                                       AIHW and simHealth Data

# data[].attributes.subject
                                                                       AIHW and simHealth Data

# data[].attributes.headline
                  Reports and Projection Data

# data[].attributes.subject
                  Reports and Projection Data

# data[].attributes.headline
                               Research Assistance

# data[].attributes.subject
                               Research Assistance

# data[].attributes.headline
                                 Organised Meetings

# data[].attributes.subject
                                 Organised Meetings

# data[].attributes.attachment_link.entities[].name
Applying Health Economic Tools and Techniques

# data[].attributes.attachment_link.title
Why do we need economic evaluation methods guides?

# data[].attributes.attachment_link.description
We've got an economic evaluation programme up and running, but inconsistencies between evaluations mean that we need quite detailed methods guides

# data[].attributes.body
Population data from About Us; History and simHealth Facts

# data[].attributes.headline
Decision Making in Health Services Management

# data[].attributes.subject
Decision Making in Health Services Management

# data[].attributes.body
Assessment:
Students make a decision based on the data and information provided.  Students are required to recommend the preferred treatment, the economic tool’s to use to inform the decision and justify the choice.  Students are to prepare a presentation of their findings.  The presentation is to be annotated.

# data[].attributes.body
Dr Samantha Smart the Chairperson of the Clinical Governance Committee has received 2 proposals regarding new treatment options for cancer patients.  One proposal is from Dr Debbie Diddler the Clinical Director, Specialty and Procedural Services proposing that SIM General invest in nano-surgery technology for the treatment of lymphoma.  The other proposal is from Dr William Wart the Clinical Director of Cancer and Support Services proposing an investment in a Phage laboratory where tailor made phage serums are made to specifically treat each patient’s leukaemia.

Dr Smart decides to meet with each of the clinical directors and to undertake her own research to assess the health economics of each proposal.